Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis

Cancer Prevention Research

Volumn 2, Issue 3, 2009, Pages 224-233

  Hung, Kenneth E ^a,b,f   Faca, Vitor ^c   Song, Kenneth ^c   Sarracino, David A ^b   Richard, Larissa Georgeon ^b   Krastins, Bryan ^b   Forrester, Sara ^d   Porter, Andrew ^d   Kunin, Alexandra ^e   Mahmood, Umar ^e   Haab, Brian B ^d   Hanash, Samir M ^c   Kucherlapati, Raju ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CATHEPSIN B; CATHEPSIN D; CULLIN; ONCOPROTEIN; PARKINSON DISEASE 7 PROTEIN; PYRUVATE KINASE; RAN PROTEIN; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE; GENE EXPRESSION; GENETIC ENGINEERING; IMMUNOCHEMISTRY; LIQUID CHROMATOGRAPHY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE LEVEL; UPREGULATION; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BLOOD PROTEINS; CELL MEMBRANE; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PROTEOMICS; RAN GTP-BINDING PROTEIN;

EID: 68349105689     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0153     Document Type: Article

References (48)

1. Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005;5:199-209. (Pubitemid 40314951)
2. Rockey DC, Barish M, Brill JV, et al. Standards for gastroenterologists for performing and interpreting diagnostic computed tomographic colonography. Gastroenterology 2007;133:1005-1024 (Pubitemid 47376890)
3. Lieberman R. Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am J Ther 2004;11:501-506
4. Badgwell D, Bast RC Jr. Early detection of ovarian cancer. Dis Markers 2007;23:397-410.
5. Katz MH, Savides TJ, Moossa AR, Bouvet M. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology 2005;5:576-590
6. Duffy MJ, van Dalen A, Haglund C, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348-1360 (Pubitemid 46874070)
7. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature 2008;452:571-579
8. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170
9. Taketo MM. Mouse models of gastrointestinal tumors. Cancer Sci 2006;97:355-361
10. Kuraguchi M, Wang XP, Branson RT, et al. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet 2006;2:e146. (Pubitemid 44504788)
11. Faca V, Coram M, Phanstiel D, et al. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res 2006;5:2009-2018 (Pubitemid 44232714)
12. Rauch A, Bellew M, Eng J, et al. Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res 2006;5:112-121 (Pubitemid 43100802)
13. MacLean B, Eng JK, Beavis RC, McIntosh M. General framework for developing and evaluating database scoring algorithms using the TANDEM search engine. Bioinformatics 2006;22:2830-2832 (Pubitemid 44742409)
14. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002;74:5383-5392 (Pubitemid 35215372)
15. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003;75:4646-4658 (Pubitemid 37082259)
16. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003;31:3784-3788 (Pubitemid 37442246)
17. Tanabe L, Scherf U, Smith LH, Lee JK, Hunter L, Weinstein JN. MedMiner: an Internet text-mining tool for biomedical information, with application to gene expression profiling. Biotechniques 1999;27:1210-1214, 6-7..
18. Perez-Iratxeta C, Perez AJ, Bork P, Andrade MA. Update on XplorMed: a web server for exploring scientific literature. Nucleic Acids Res 2003;31:3866-3868 (Pubitemid 37442266)
19. Al-Shahrour F, Diaz-Uriarte R, Dopazo J. FatiGO: a web tool for finding significant associations of gene ontology terms with groups of genes. Bioinformatics 2004;20:578-580 (Pubitemid 38344339)
20. Dennis G, Jr., Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
21. Hung KE, Kho AT, Sarracino D, et al. Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. J Proteome Res 2006;5:1866-1878 (Pubitemid 44235755)
22. Paoni NF, Feldman MW, Gutierrez LS, Ploplis VA, Castellino FJ. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Physiol Genomics 2003;15:228-235
23. Funovics MA, Alencar H, Montet X, Weissleder R, Mahmood U. Simultaneous fluorescence imaging of protease expression and vascularity during murine colonoscopy for colonic lesion characterization. Gastrointest Endosc 2006;64:589-597 (Pubitemid 44397063)
24. Ward DG, Suggett N, Cheng Y, et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006;94:1898-1905 (Pubitemid 43882582)
25. Chaurand P, DaGue BB, Pearsall RS, Threadgill DW, Caprioli RM. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2001;1:1320-1326 (Pubitemid 33587887)
26. Friedman DB, Hill S, Keller JW, et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004;4:793-811. (Pubitemid 38339157)
27. Balasubramani M, Day BW, Schoen RE, Getzenberg RH. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res 2006;66:763-769 (Pubitemid 43165940)
28. Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004;5:739-751 (Pubitemid 39208183)
29. Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 2005;16:323-333 (Pubitemid 40504221)
30. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999;1:193-199
31. Nakayama K, Nagahama H, Minamishima YA, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000;19:2069-2081
32. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-234 (Pubitemid 27064711)
33. Philipp-Staheli J, Kim K-H, Payne SR, et al. Pathway-specific tumor suppression: reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 2002;1:355-368 (Pubitemid 41039137)
34. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett 1995;96:267-275
35. Campo E, Munoz J, Miquel R, et al. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 1994;145:301-309 (Pubitemid 24245830)
36. Sebzda T, Saleh Y, Gburek J, et al. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade. J Exp Ther Oncol 2005;5:145-150 (Pubitemid 41739374)
37. Talieri M, Papadopoulou S, Scorilas A, et al. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett 2004;205:97-106. (Pubitemid 38230144)
38. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005;15:300-308
39. Eigenbrodt E, Basenau D, Holthusen S, Mazurek S, Fischer G. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas. Anticancer Res 1997;17:3153-3156 (Pubitemid 27434880)
40. Hardt PD, Mazurek S, Toepler M, et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer 2004;91:980-984 (Pubitemid 39273794)
41. Mazurek S, Grimm H, Oehmke M, Weisse G, Teigelkamp S, Eigenbrodt E. Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells. Anticancer Res 2000;20:5151-5154 (Pubitemid 32319099)
42. Christofk HR, Vander Heiden MG, Harris MH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452:230-233
43. van Duijn CM, Dekker MC, Bonifati V, et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001;69:629-634 (Pubitemid 32777700)
44. Nagakubo D, Taira T, Kitaura H, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997;231:509-513 (Pubitemid 27214343)
45. Kim RH, Peters M, Jang Y, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263-273 (Pubitemid 40568685)
46. Le Naour F, Misek DE, Krause MC, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 2001;7:3328-3335 (Pubitemid 33069962)
47. Quimby BB, Dasso M. The small GTPase Ran: interpreting the signs. Curr Opin Cell Biol 2003;15:338-344 (Pubitemid 36638653)
48. Faca VM, Song KS, Wang H, et al. A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 2008;5:e123. (Pubitemid 351919117)